InvestorsHub Logo
Followers 91
Posts 11325
Boards Moderated 0
Alias Born 06/06/2014

Re: dadofmarcmax post# 141148

Thursday, 02/15/2018 4:01:44 PM

Thursday, February 15, 2018 4:01:44 PM

Post# of 461229
Hopefully. There's a number of more potent S1 agonists out there in use already, so that in itself isn't promising. I'm looking forward to dose related (real dose related, not BS) clinical improvement. The AD data so far is problematic, I have higher hopes for the RS trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News